175 related articles for article (PubMed ID: 30315452)
1. Animal Model of Aluminum-Induced Alzheimer's Disease.
Song J
Adv Exp Med Biol; 2018; 1091():113-127. PubMed ID: 30315452
[TBL] [Abstract][Full Text] [Related]
2. A new insight on Al-maltolate-treated aged rabbit as Alzheimer's animal model.
Bharathi ; Shamasundar NM; Sathyanarayana Rao TS; Dhanunjaya Naidu M; Ravid R; Rao KS
Brain Res Rev; 2006 Sep; 52(2):275-92. PubMed ID: 16782202
[TBL] [Abstract][Full Text] [Related]
3. Molecular toxicity of aluminium in relation to neurodegeneration.
; Vasudevaraju P; Govindaraju M; Palanisamy AP; Sambamurti K; Rao KS
Indian J Med Res; 2008 Oct; 128(4):545-56. PubMed ID: 19106446
[TBL] [Abstract][Full Text] [Related]
4. Experimental aluminum encephalomyelopathy. Relationship to human neurodegenerative disease.
Rao JK; Katsetos CD; Herman MM; Savory J
Clin Lab Med; 1998 Dec; 18(4):687-98, viii. PubMed ID: 9891607
[TBL] [Abstract][Full Text] [Related]
5. Neurofibrillary lesions in experimental aluminum-induced encephalopathy and Alzheimer's disease share immunoreactivity for amyloid precursor protein, A beta, alpha 1-antichymotrypsin and ubiquitin-protein conjugates.
Huang Y; Herman MM; Liu J; Katsetos CD; Wills MR; Savory J
Brain Res; 1997 Oct; 771(2):213-20. PubMed ID: 9401741
[TBL] [Abstract][Full Text] [Related]
6. Exposure to Aluminum in Daily Life and Alzheimer's Disease.
Nie J
Adv Exp Med Biol; 2018; 1091():99-111. PubMed ID: 30315451
[TBL] [Abstract][Full Text] [Related]
7. Reversal by desferrioxamine of tau protein aggregates following two days of treatment in aluminum-induced neurofibrillary degeneration in rabbit: implications for clinical trials in Alzheimer's disease.
Savory J; Huang Y; Wills MR; Herman MM
Neurotoxicology; 1998 Apr; 19(2):209-14. PubMed ID: 9553957
[TBL] [Abstract][Full Text] [Related]
8. Aluminum intoxication and the victim of Alzheimer's disease: similarities and differences.
Yokel RA; Provan SD; Meyer JJ; Campbell SR
Neurotoxicology; 1988; 9(3):429-42. PubMed ID: 3059244
[TBL] [Abstract][Full Text] [Related]
9. Neuropathologic, neurochemical and immunocytochemical characteristics of aluminum-induced neurofilamentous degeneration.
Pendlebury WW; Beal MF; Kowall NW; Solomon PR
Neurotoxicology; 1988; 9(3):503-10. PubMed ID: 3200512
[TBL] [Abstract][Full Text] [Related]
10. The association of aluminum Alzheimer's disease, and neurofibrillary tangles.
Perl DP; Good PF
J Neural Transm Suppl; 1987; 24():205-11. PubMed ID: 3316495
[TBL] [Abstract][Full Text] [Related]
11. Necrostatin-1 Relieves Learning and Memory Deficits in a Zebrafish Model of Alzheimer's Disease Induced by Aluminum.
Gao X; Zhang P; Chen J; Zhang L; Shang N; Chen J; Fan R; Wang Y; Huang T; Niu Q; Zhang Q
Neurotox Res; 2022 Feb; 40(1):198-214. PubMed ID: 34982355
[TBL] [Abstract][Full Text] [Related]
12. An aluminum-based rat model for Alzheimer's disease exhibits oxidative damage, inhibition of PP2A activity, hyperphosphorylated tau, and granulovacuolar degeneration.
Walton JR
J Inorg Biochem; 2007 Sep; 101(9):1275-84. PubMed ID: 17662457
[TBL] [Abstract][Full Text] [Related]
13. A molecular mechanism of aluminium-induced Alzheimer's disease?
Exley C
J Inorg Biochem; 1999 Aug; 76(2):133-40. PubMed ID: 10612066
[TBL] [Abstract][Full Text] [Related]
14. First magenetic resonance imaging studies on aluminium maltolate-treated aged New Zealand rabbits: an Alzheimer's animal model.
Magisetty O; Dowlathabad MR; Raichurkar KP; Mannar SN
Psychogeriatrics; 2016 Jul; 16(4):263-7. PubMed ID: 26419490
[TBL] [Abstract][Full Text] [Related]
15. Role of deferoxamine on enzymatic stress markers in an animal model of Alzheimer's disease after chronic aluminum exposure.
Esparza JL; Garcia T; Gómez M; Nogués MR; Giralt M; Domingo JL
Biol Trace Elem Res; 2011 Jun; 141(1-3):232-45. PubMed ID: 20455029
[TBL] [Abstract][Full Text] [Related]
16. APP/PS1 transgenic mice treated with aluminum: an update of Alzheimer's disease model.
Zhang QL; Jia L; Jiao X; Guo WL; Ji JW; Yang HL; Niu Q
Int J Immunopathol Pharmacol; 2012; 25(1):49-58. PubMed ID: 22507317
[TBL] [Abstract][Full Text] [Related]
17. Would decreased aluminum ingestion reduce the incidence of Alzheimer's disease?
McLachlan DR; Kruck TP; Lukiw WJ; Krishnan SS
CMAJ; 1991 Oct; 145(7):793-804. PubMed ID: 1822096
[TBL] [Abstract][Full Text] [Related]
18. Chronic exposure to aluminum and risk of Alzheimer's disease: A meta-analysis.
Wang Z; Wei X; Yang J; Suo J; Chen J; Liu X; Zhao X
Neurosci Lett; 2016 Jan; 610():200-6. PubMed ID: 26592479
[TBL] [Abstract][Full Text] [Related]
19. Co-involvement of mitochondria and endoplasmic reticulum in regulation of apoptosis: changes in cytochrome c, Bcl-2 and Bax in the hippocampus of aluminum-treated rabbits.
Ghribi O; DeWitt DA; Forbes MS; Herman MM; Savory J
Brain Res; 2001 Jun; 903(1-2):66-73. PubMed ID: 11382389
[TBL] [Abstract][Full Text] [Related]
20. Aluminum: a possible neurotoxic agent in Alzheimer's disease.
Crapper DR; Krishnan SS; De Boni U; Tomko GJ
Trans Am Neurol Assoc; 1975; 100():154-6. PubMed ID: 1241624
[No Abstract] [Full Text] [Related]
[Next] [New Search]
